Posterior reversible encephalopathy syndrome

Journal of Intensive Care Medicine

Volumn 27, Issue 1, 2012, Pages 11-24

  Staykov, Dimitre ^a   Schwab, Stefan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

eclampsia; hypertensive encephalopathy; posterior reversible encephalopathy syndrome; reversible posterior leukoencephalopathy syndrome

Indexed keywords

AZATHIOPRINE; BARBITURIC ACID; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIAZEPAM; DIAZOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LORAZEPAM; MAGNESIUM SULFATE; MIDAZOLAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; PHENYTOIN; PROPOFOL; RITUXIMAB;

ARTICLE; BRAIN EDEMA; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ECLAMPSIA; FETUS DISEASE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; NEPHROTOXICITY; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SEIZURE;

ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CEREBROVASCULAR CIRCULATION; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; HYPERTENSIVE ENCEPHALOPATHY; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; ORGAN TRANSPLANTATION; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRE-ECLAMPSIA; PREGNANCY;

EID: 84856132938     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610393634     Document Type: Article

References (186)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 ; 334 (8). 494-500 (Pubitemid 26067737)
2. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol. 1995 ; 165 (3). 627-631
3. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992 ; 159 (2). 379-383
4. Hauser RA, Lacey DM, Knight MR.. Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988 ; 45 (10). 1078-1083
5. Schwartz RB.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 ; 334 (26). 1743
6. Pavlakis SG, Frank Y, Kalina P, Chandra M, Lu D.. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol. 1997 ; 16 (2). 145-148 (Pubitemid 27137452)
7. Narbone MC, Musolino R, Granata F, Mazzu I, Abbate M, Ferlazzo E.. PRES: posterior or potentially reversible encephalopathy syndrome?. Neurol Sci. 2006 ; 27 (3). 187-189 (Pubitemid 44161046)
8. Maizlin ZV, Ghandehari H, Maizels L, et al. Linguistic history of posterior reversible encephalopathy syndrome: mirror of developing knowledge. J Neuroimaging. 2009 ;:
9. Bartynski WS, Boardman JF.. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007 ; 28 (7). 1320-1327 (Pubitemid 47309666)
10. Casey SO, Sampaio RC, Michel E, Truwit CL.. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000 ; 21 (7). 1199-1206 (Pubitemid 30655653)
11. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA.. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008 ; 65 (2). 205-210 (Pubitemid 351240781)
12. Garg RK.. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001 ; 77 (903). 24-28 (Pubitemid 32055944)
13. Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007 ; 33 (2). 230-236 (Pubitemid 46221227)
14. Bartynski WS.. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008 ; 29 (6). 1036-1042 (Pubitemid 351954863)
15. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J.. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006 ; 27 (10). 2179-2190 (Pubitemid 44788652)
16. Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW.. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008 ; 29 (5). 924-930 (Pubitemid 351684968)
17. Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF.. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr. 1997 ; 21 (6). 872-880 (Pubitemid 28049575)
18. Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J.. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol. 2001 ; 22 (10). 1901-1914 (Pubitemid 33091961)
19. Roth C, Ferbert A.. Posterior reversible encephalopathy syndrome-long-term follow-up. J Neurol Neurosurg Psychiatry. 2010 ; 81 (7). 773-777
20. Ahn KJ, You WJ, Jeong SL, et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology. 2004 ; 46 (12). 978-983 (Pubitemid 40823322)
21. Lamy C, Oppenheim C, Meder JF, Mas JL.. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004 ; 14 (2). 89-96 (Pubitemid 38391815)
22. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F.. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998 ; 19 (5). 859-862 (Pubitemid 30415767)
23. Ugurel MS, Hayakawa M.. Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome. Eur J Radiol. 2005 ; 53 (3). 441-449 (Pubitemid 40312134)
24. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007 ; 189 (4). 904-912 (Pubitemid 47485623)
25. Covarrubias DJ, Luetmer PH, Campeau NG.. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002 ; 23 (6). 1038-1048 (Pubitemid 34663453)
26. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology. 1998 ; 51 (5). 1369-1376 (Pubitemid 28520560)
27. Benziada-Boudour A, Schmitt E, Kremer S, et al. Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol. 2009 ; 36 (2). 102-105
28. Sengar AR, Gupta RK, Dhanuka AK, Roy R, Das K.. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol. 1997 ; 18 (8). 1485-1490 (Pubitemid 30413963)
29. Eichler FS, Wang P, Wityk RJ, Beauchamp NJ, Barker PB.. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 2002 ; 23 (5). 833-837 (Pubitemid 34525702)
30. Russell MT, Nassif AS, Cacayorin ED, Awwad E, Perman W, Dunphy F.. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging. 2001 ; 19 (1). 129-132 (Pubitemid 32274125)
31. Lee SY, Kim SH, Lee SH, Baek HJ, Shon HS, Kim SS.. Serial MR spectroscopy in relapsing reversible posterior leukoencephalopathy syndrome. Neurologist. 2009 ; 15 (6). 338-341
32. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D.. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?. Neuroradiology. 2009 ; 51 (6). 373-383
33. Schwartz RB.. Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist. 2002 ; 8 (1). 22-34 (Pubitemid 34111563)
34. Jones BV, Egelhoff JC, Patterson RJ.. Hypertensive encephalopathy in children. AJNR Am J Neuroradiol. 1997 ; 18 (1). 101-106 (Pubitemid 27036636)
35. Weier K, Fluri F, Kos S, Gass A.. Postcontrast flair MRI demonstrates blood-brain barrier dysfunction in PRES. Neurology. 2009 ; 72 (8). 760-762
36. Hefzy HM, Bartynski WS, Boardman JF, Lacomis D.. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009 ; 30 (7). 1371-1379
37. Singhal AB.. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004 ; 61 (3). 411-416 (Pubitemid 38327360)
38. Smeda JS, Payne GW.. Alterations in autoregulatory and myogenic function in the cerebrovasculature of Dahl salt-sensitive rats. Stroke. 2003 ; 34 (6). 1484-1490 (Pubitemid 36693522)
39. Apollon KM, Robinson JN, Schwartz RB, Norwitz ER.. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol. 2000 ; 95 (6 pt 2). 1017-1019 (Pubitemid 30251943)
40. Schwartz R, Mulkern R, Vajapeyam S, Kacher DF.. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2009 ; 30 (2). E19
41. Bartynski WS, Boardman JF.. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008 ; 29 (3). 447-455 (Pubitemid 351424055)
42. Lin JT, Wang SJ, Fuh JL, Hsiao LT, Lirng JF, Chen PM.. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol. 2003 ; 24 (1). 102-104
43. Brubaker LM, Smith JK, Lee YZ, Lin W, Castillo M.. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol. 2005 ; 26 (4). 825-830 (Pubitemid 43079775)
44. Engelter ST, Petrella JR, Alberts MJ, Provenzale JM.. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol. 1999 ; 173 (6). 1491-1493
45. Naidu K, Moodley J, Corr P, Hoffmann M.. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol. 1997 ; 104 (10). 1165-1172 (Pubitemid 27406488)
46. Casey SO, McKinney A, Teksam M, Liu H, Truwit CL.. CT perfusion imaging in the management of posterior reversible encephalopathy. Neuroradiology. 2004 ; 46 (4). 272-276 (Pubitemid 38594248)
47. Lewis LK, Hinshaw DB, Will AD, Hasso AN, Thompson JR.. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology. 1988 ; 30 (1). 59-64 (Pubitemid 18057854)
48. Trommer BL, Homer D, Mikhael MA.. Cerebral vasospasm and eclampsia. Stroke. 1988 ; 19 (3). 326-329
49. Will AD, Lewis KL, Hinshaw DB, et al. Cerebral vasoconstriction in toxemia. Neurology. 1987 ; 37 (9). 1555-1557 (Pubitemid 17132346)
50. Bartynski WS, Sanghvi A.. Neuroimaging of delayed eclampsia. Report of 3 cases and review of the literature. J Comput Assist Tomogr. 2003 ; 27 (5). 699-713 (Pubitemid 37087739)
51. Geraghty JJ, Hoch DB, Robert ME, Vinters HV.. Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology. 1991 ; 41 (7). 1145-1147
52. Ito T, Sakai T, Inagawa S, Utsu M, Bun T.. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol. 1995 ; 16 (6). 1344-1346
53. Thaipisuttikul I, Phanthumchinda K.. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol. 2005 ; 252 (2). 230-231 (Pubitemid 40385601)
54. Sweany JM, Bartynski WS, Boardman JF.. "Recurrent" posterior reversible encephalopathy syndrome: report of 3 cases-PRES can strike twice!. J Comput Assist Tomogr. 2007 ; 31 (1). 148-156 (Pubitemid 46183354)
55. Fisher M, Maister B, Jacobs R.. Hypertensive encephalopathy: diffuse reversible white matter CT abnormalities. Ann Neurol. 1985 ; 18 (2). 268-270
56. Rail DL, Perkin GD.. Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol. 1980 ; 37 (5). 310-311 (Pubitemid 10000977)
57. Weingarten K, Barbut D, Filippi C, Zimmerman RD.. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol. 1994 ; 162 (3). 665-670 (Pubitemid 24093575)
58. Lin KL, Hsu WC, Wang HS, Lui TN.. Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr Neurol. 2006 ; 34 (1). 72-75
59. Kwong YL, Yu YL, Lam KS, Woo E, Ma JT, Huang CY.. CT appearance in hypertensive encephalopathy. Neuroradiology. 1987 ; 29 (2). 215 (Pubitemid 17041550)
60. Weingarten KL, Zimmerman RD, Pinto RS, Whelan MA.. Computed tomographic changes of hypertensive encephalopathy. AJNR Am J Neuroradiol. 1985 ; 6 (3). 395-398 (Pubitemid 15067366)
61. Colosimo C, Fileni A, Moschini M, Guerrini P.. CT findings in eclampsia. Neuroradiology. 1985 ; 27 (4). 313-317 (Pubitemid 15030944)
62. Naheedy MH, Biller J, Schiffer M, Azar-Kia B, Gianopoulous J, Zarandy S.. Toxemia of pregnancy: cerebral CT findings. J Comput Assist Tomogr. 1985 ; 9 (3). 497-501
63. Waldron RL, Abbott DC, Vellody D.. Computed tomography in preeclampsia-eclampsia syndrome. AJNR Am J Neuroradiol. 1985 ; 6 (3). 442-443 (Pubitemid 15067376)
64. Koch S, Rabinstein A, Falcone S, Forteza A.. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol. 2001 ; 22 (6). 1068-1070 (Pubitemid 32587417)
65. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH.. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke. 1997 ; 28 (5). 1082-1085 (Pubitemid 27209161)
66. Raroque HG, Orrison WW, Rosenberg GA.. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology. 1990 ; 40 (1). 167-169 (Pubitemid 20032917)
67. Sanders TG, Clayman DA, Sanchez-Ramos L, Vines FS, Russo L.. Brain in eclampsia: MR imaging with clinical correlation. Radiology. 1991 ; 180 (2). 475-478
68. Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000 ; 217 (2). 371-376
69. Marik PE.. Hypertensive disorders of pregnancy. Postgrad Med. 2009 ; 121 (2). 69-76
70. Powell ES, Goldman MJ.. Posterior reversible encephalopathy syndrome (PRES) in a thirty-six-week gestation eclamptic. J Emerg Med. 2007 ; 33 (4). 377-379 (Pubitemid 350181253)
71. Servillo G, Apicella E, Striano P.. Posterior reversible encephalopathy syndrome (PRES) in the parturient with preeclampsia after inadvertent dural puncture. Int J Obstet Anesth. 2008 ; 17 (1). 88-89 (Pubitemid 350298882)
72. Torrillo TM, Bronster DJ, Beilin Y.. Delayed diagnosis of posterior reversible encephalopathy syndrome (PRES) in a parturient with preeclampsia after inadvertent dural puncture. Int J Obstet Anesth. 2007 ; 16 (2). 171-174 (Pubitemid 46401251)
73. Roth C, Ferbert A.. Posterior reversible encephalopathy syndrome: is there a difference between pregnant and non-pregnant patients?. Eur Neurol. 2009 ; 62 (3). 142-148
74. Zeeman GG.. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009 ; 33 (3). 166-172
75. Okanloma KA, Moodley J.. Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet. 2000 ; 71 (3). 223-225
76. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1999 ; 181 (4). 924-928 (Pubitemid 29503617)
77. Sibai BM.. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol. 1990 ; 163 (3). 1049-1054
78. Dekker GA, Sibai BM.. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998 ; 179 (5). 1359-1375 (Pubitemid 28533800)
79. Delefosse D, Samain E, Helias A, et al. Late onset of cortical blindness in a patient with severe preeclampsia related to retained placental fragments. Anesthesiology. 2003 ; 98 (1). 261-263 (Pubitemid 36043434)
80. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant. 1991 ; 8 (5). 393-401
81. Kishi Y, Miyakoshi S, Kami M, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant. 2004 ; 10 (8). 561-568 (Pubitemid 39022916)
82. Wong R, Beguelin GZ, de Lima M, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2003 ; 122 (1). 128-134 (Pubitemid 36819347)
83. Zimmer WE, Hourihane JM, Wang HZ, Schriber JR.. The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 1998 ; 19 (4). 601-608 (Pubitemid 30422700)
84. Kanekiyo T, Hara J, Matsuda-Hashii Y, et al. Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int J Hematol. 2005 ; 81 (3). 264-268 (Pubitemid 41364494)
85. de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA.. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med. 1987 ; 317 (14). 861-866 (Pubitemid 17156729)
86. Truwit CL, Denaro CP, Lake JR, DeMarco T.. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol. 1991 ; 12 (4). 651-659
87. Wilson SE, de Groen PC, Aksamit AJ, Wiesner RH, Garrity JA, Krom RA.. Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol. 1988 ; 8 (4). 215-220 (Pubitemid 19007789)
88. Nussbaum ES, Maxwell RE, Bitterman PB, Hertz MI, Bula W, Latchaw RE.. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report. J Neurosurg. 1995 ; 82 (6). 1068-1070
89. Furukawa M, Terae S, Chu BC, Kaneko K, Kamada H, Miyasaka K.. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology. 2001 ; 43 (8). 615-621 (Pubitemid 32755681)
90. Jarosz JM, Howlett DC, Cox TC, Bingham JB.. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology. 1997 ; 39 (10). 711-715 (Pubitemid 27425064)
91. Small SL, Fukui MB, Bramblett GT, Eidelman BH.. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol. 1996 ; 40 (4). 575-580 (Pubitemid 26357881)
92. Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RB. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol. 1996 ; 166 (3). 683-688 (Pubitemid 26065184)
93. Lanzino G, Cloft H, Hemstreet MK, West K, Alston S, Ishitani M.. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg. 1997 ; 99 (3). 222-226 (Pubitemid 27412449)
94. Shimono T, Miki Y, Toyoda H, et al. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol. 2003 ; 13 (5). 986-993 (Pubitemid 36790591)
95. Besenski N, Rumboldt Z, Emovon O, et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol. 2005 ; 26 (9). 2282-2289
96. Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR.. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol. 2001 ; 16 (7). 537-542 (Pubitemid 32600155)
97. Reinohs M, Straube T, Baum P, Berrouschot J, Wagner A.. Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol. 2002 ; 249 (6). 780-781 (Pubitemid 34651764)
98. Bartynski WS, Zeigler ZR, Shadduck RK, Lister J.. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 2004 ; 25 (2). 261-269 (Pubitemid 38235306)
99. Bartynski WS, Zeigler ZR, Shadduck RK, Lister J.. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care. 2005 ; 3 (1). 33-45 (Pubitemid 41278391)
100. Chohan R, Vij R, Adkins D, et al. Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity. Br J Haematol. 2003 ; 123 (1). 110-113 (Pubitemid 37222766)
101. Provenzale JM, Graham ML.. Reversible leukoencephalopathy associated with graft-versus-host disease: MR findings. AJNR Am J Neuroradiol. 1996 ; 17 (7). 1290-1294 (Pubitemid 26277367)
102. Singh N, Bonham A, Fukui M.. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000 ; 69 (4). 467-472 (Pubitemid 30129574)
103. Wijdicks EF.. Neurotoxicity of immunosuppressive drugs. Liver Transpl. 2001 ; 7 (11). 937-942 (Pubitemid 33085781)
104. Cooney MJ, Bradley WG, Symko SC, Patel ST, Groncy PK.. Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders-report of three cases. Radiology. 2000 ; 214 (3). 711-716 (Pubitemid 30115369)
105. Morris EB, Laningham FH, Sandlund JT, Khan RB.. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer. 2007 ; 48 (2). 152-159 (Pubitemid 44958271)
106. Sanchez-Carpintero R, Narbona J, Lopez de Mesa R, Arbizu J, Sierrasesumaga L.. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr Neurol. 2001 ; 24 (2). 145-148 (Pubitemid 32280299)
107. Pihko H, Tyni T, Virkola K, et al. Transient ischemic cerebral lesions during induction chemotherapy for acute lymphoblastic leukemia. J Pediatr. 1993 ; 123 (5). 718-724 (Pubitemid 23316422)
108. Patel AG, Rao R.. Transient Ara-C leukoencephalopathy: MR findings. J Comput Assist Tomogr. 1996 ; 20 (1). 161-162 (Pubitemid 26044048)
109. Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA.. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol. 1993 ; 14 (4). 1014-1016 (Pubitemid 23213398)
110. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998 ; 19 (3). 415-417 (Pubitemid 30422741)
111. Rippe DJ, Edwards MK, Schrodt JF, Bognanno JR, D'Amour PG, Boyko OB.. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr. 1988 ; 12 (6). 1078-1081
112. Glusker P, Recht L, Lane B.. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006 ; 354 (9). 980-982
113. Ozcan C, Wong SJ, Hari P.. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006 ; 354 (9). 980-982
114. Bell CL, Partington C, Robbins M, Graziano F, Turski P, Kornguth S.. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum. 1991 ; 34 (4). 432-441
115. Cassano G, Gongora V, Zunino A, Roverano S, Paira S.. Reversible posterior leukoencephalopathy in systemic lupus erythematosus with thrombotic thrombocytopenic purpura. J Clin Rheumatol. 2007 ; 13 (1). 55-57 (Pubitemid 46213851)
116. Foocharoen C, Tiamkao S, Srinakarin J, Chamadol N, Sawanyawisuth K.. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus. J Med Assoc Thai. 2006 ; 89 (7). 1029-1032 (Pubitemid 44099149)
117. Gocmen R, Ozgen B, Oguz KK.. Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol. 2007 ; 62 (3). 454-459 (Pubitemid 46783357)
118. Kur JK, Esdaile JM.. Posterior reversible encephalopathy syndrome-an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol. 2006 ; 33 (11). 2178-2183 (Pubitemid 44749776)
119. Lateef A, Lim AY.. Case reports of transient loss of vision and systemic lupus erythematosus. Ann Acad Med Singapore. 2007 ; 36 (2). 146-149 (Pubitemid 46640268)
120. Magnano MD, Bush TM, Herrera I, Altman RD.. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2006 ; 35 (6). 396-402 (Pubitemid 43831154)
121. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M.. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford). 2004 ; 43 (11). 1450-1451 (Pubitemid 39480939)
122. Mukherjee P, McKinstry RC.. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology. 2001 ; 219 (3). 756-765 (Pubitemid 32476268)
123. Ozyurek H, Oguz G, Ozen S, et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005 ; 20 (12). 990-993
124. Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK.. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?. Pediatr Nephrol. 2003 ; 18 (11). 1161-1166 (Pubitemid 37406866)
125. Primavera A, Audenino D, Mavilio N, Cocito L.. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis. 2001 ; 60 (5). 534-537 (Pubitemid 32417432)
126. Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA.. Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol. 1996 ; 36 (1). 25-28
127. Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW.. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol. 2005 ; 11 (3). 164-166 (Pubitemid 40863831)
128. Yong PF, Hamour SM, Burns A.. Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant. 2003 ; 18 (12). 2660-2662 (Pubitemid 37483804)
129. Punaro M, Abou-Jaoude P, Cimaz R, Ranchin B.. Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus. 2007 ; 16 (8). 576-579 (Pubitemid 47359991)
130. Dy GK, Swaroop VS.. 31-year-old woman with confusion and labile behavior. Mayo Clin Proc. 2002 ; 77 (6). 557-560 (Pubitemid 34587345)
131. Ishimori ML, Pressman BD, Wallace DJ, Weisman MH.. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE?. Lupus. 2007 ; 16 (6). 436-443 (Pubitemid 47122218)
132. Ozgencil E, Gulucu C, Yalcyn S, et al. Seizures and loss of vision in a patient with systemic lupus erythematosus. Neth J Med. 2007 ; 65 (7). 274 (Pubitemid 47232746)
133. Leroux G, Sellam J, Costedoat-Chalumeau N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus. 2008 ; 17 (2). 139-147 (Pubitemid 351346449)
134. Min L, Zwerling J, Ocava LC, Chen IH, Putterman C.. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum. 2006 ; 35 (6). 388-395 (Pubitemid 43841894)
135. Gijtenbeek JM, van den Bent MJ, Vecht CJ.. Cyclosporine neurotoxicity: a review. J Neurol. 1999 ; 246 (5). 339-346 (Pubitemid 29261421)
136. Kastrup O, Maschke M, Wanke I, Diener HC.. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002 ; 249 (11). 1563-1566 (Pubitemid 35477899)
137. Ma ES, Chiu EK, Fong GC, Li FK, Wong CL.. Burkitt lymphoma presenting as posterior reversible encephalopathy syndrome secondary to hypercalcaemia. Br J Haematol. 2009 ; 146 (6). 584
138. Fabbian F, Pala M, Fallica E, et al. Posterior reversible encephalopathy syndrome in an 87-year-old woman with Escherichia coli bloodstream infection. Clin Exp Nephrol. 2010 ; 14 (2). 176-179
139. Belmouaz S, Desport E, Leroy F, et al. Posterior reversible encephalopathy induced by intravenous immunoglobulin. Nephrol Dial Transplant. 2008 ; 23 (1). 417-419 (Pubitemid 351767393)
140. Koichihara R, Hamano S, Yamashita S, Tanaka M.. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barre syndrome. Pediatr Neurol. 2008 ; 39 (2). 123-125 (Pubitemid 351970656)
141. Sutter R, Mengiardi B, Lyrer P, Czaplinski A.. Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barre syndrome. Neuromuscul Disord. 2009 ; 19 (10). 709-710
142. Sanelli PC, Jacobs MA, Ougorets I, Mifsud MJ.. Posterior reversible encephalopathy syndrome on computed tomography perfusion in a patient on "Triple H" therapy. Neurocrit Care. 2005 ; 3 (1). 46-50 (Pubitemid 41278392)
143. Wartenberg KE, Parra A.. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006 ; 16 (2). 170-175
144. Moawad FJ, Hartzell JD, Biega TJ, Lettieri CJ.. Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose. South Med J. 2006 ; 99 (5). 511-514 (Pubitemid 43804521)
145. Ozkan A, Hakyemez B, Ozkalemkas F, et al. Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology. 2006 ; 48 (12). 887-892 (Pubitemid 44834108)
146. Cannon G, Caravati EM, Filloux FM.. Hydrogen peroxide neurotoxicity in childhood: case report with unique magnetic resonance imaging features. J Child Neurol. 2003 ; 18 (11). 805-808 (Pubitemid 38016579)
147. Sukumaran S, George B, Nair HP, Drobyski WR.. Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT. Bone Marrow Transplant. 2010 ; 45 (4). 779-780
148. Bartynski WS, Upadhyaya AR, Boardman JF.. Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature. J Comput Assist Tomogr. 2009 ; 33 (6). 917-922
149. Ranu Alpay N, Satar S, Sebe A, Demir M, Topal M.. Unusual presentations of scorpion envenomation. Hum Exp Toxicol. 2008 ; 27 (1). 81-85 (Pubitemid 351796809)
150. Legriel S, Bruneel F, Spreux-Varoquaux O, et al. Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care. 2008 ; 9 (2). 247-252
151. Nagel S, Kohrmann M, Huttner HB, Storch-Hagenlocher B, Schwab S.. Linezolid-induced posterior reversible leukoencephalopathy syndrome. Arch Neurol. 2007 ; 64 (5). 746-748 (Pubitemid 46789843)
152. Bartynski WS.. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008 ; 29 (6). 1043-1049 (Pubitemid 351954864)
153. Coughlin WF, McMurdo SK, Reeves T.. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr. 1989 ; 13 (4). 572-576 (Pubitemid 19183898)
154. Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES). Med Sci Monit. 2005 ; 11 (11). CR549 - CR553
155. Auer LM.. The pathogenesis of hypertensive encephalopathy. Experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochir Suppl (Wien). 1978 ; 27: 1-111
156. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol. 1978 ; 234 (4). H371 - H383
157. Kwon S, Koo J, Lee S.. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001 ; 24 (5). 361-364
158. Mark AL.. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med. 1990 ; 323 (11). 748-750 (Pubitemid 20288945)
159. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990 ; 323 (11). 693-699 (Pubitemid 20288937)
160. Ferrara JL.. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res. 2000 ; 9 (3). 299-306 (Pubitemid 30436458)
161. Schmauss D, Weis M.. Cardiac allograft vasculopathy: recent developments. Circulation. 2008 ; 117 (16). 2131-2141 (Pubitemid 351596195)
162. Savage CO, Harper L, Cockwell P, Adu D, Howie AJ.. ABC of arterial and vascular disease: vasculitis. BMJ. 2000 ; 320 (7245). 1325-1328 (Pubitemid 30245725)
163. Aird WC.. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003 ; 101 (10). 3765-3777 (Pubitemid 36857845)
164. Faraci FM, Heistad DD.. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998 ; 78 (1). 53-97 (Pubitemid 28070975)
165. Beausang-Linder M, Bill A.. Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand. 1981 ; 111 (2). 193-199 (Pubitemid 11134146)
166. Edvinsson L, Owman C, Sjoberg NO.. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res. 1976 ; 115 (3). 377-393
167. Bleys RL, Cowen T, Groen GJ, Hillen B, Ibrahim NB.. Perivascular nerves of the human basal cerebral arteries: I. Topographical distribution. J Cereb Blood Flow Metab. 1996 ; 16 (5). 1034-1047 (Pubitemid 26292072)
168. Rosengarten B, Kaps M.. Cerebral autoregulation in middle cerebral artery territory precedes that of posterior cerebral artery in human cortex. Cerebrovasc Dis. 2002 ; 13 (1). 21-25 (Pubitemid 34124166)
169. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG.. Cerebral infarction in eclampsia. Am J Obstet Gynecol. 2004 ; 190 (3). 714-720 (Pubitemid 38406783)
170. Antunes NL, Small TN, George D, Boulad F, Lis E.. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol. 1999 ; 20 (3). 241-243 (Pubitemid 29166472)
171. Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003 ; 29 (12). 2323-2326 (Pubitemid 38030688)
172. Solinas C, Briellmann RS, Harvey AS, Mitchell LA, Berkovic SF.. Hypertensive encephalopathy: antecedent to hippocampal sclerosis and temporal lobe epilepsy?. Neurology. 2003 ; 60 (9). 1534-1536 (Pubitemid 36554822)
173. Lawn N, Laich E, Ho S, et al. Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy: accident or association?. Neurology. 2004 ; 62 (8). 1352-1356 (Pubitemid 38526048)
174. Aukes AM, Wessel I, Dubois AM, Aarnoudse JG, Zeeman GG.. Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol. 2007 ; 197 (4). 365 e361 - e366
175. Brusse I, Duvekot J, Jongerling J, Steegers E, De Koning I.. Impaired maternal cognitive functioning after pregnancies complicated by severe pre-eclampsia: a pilot case-control study. Acta Obstet Gynecol Scand. 2008 ; 87 (4). 408-412 (Pubitemid 351481704)
176. Paul F, Aktas O, Dieste FJ, Kreitsch P, Vogel HP, Zipp F.. [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil]. Nervenarzt. 2006 ; 77 (6). 706-710 (Pubitemid 44124112)
177. Finsterer J, Stollberger C, Ostermann E, Zuntner G, Huber J, Tscherney R.. Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorder. Blood Press. 2009 ; 18 (3). 1-4
178. Onder AM, Lopez R, Teomete U, et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol. 2007 ; 22 (11). 1921-1929 (Pubitemid 47506233)
179. Finsterer J, Schlager T, Kopsa W, Wild E.. Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES). Neurology. 2003 ; 61 (5). 715-716 (Pubitemid 37082619)
180. Leeman L, Fontaine P.. Hypertensive disorders of pregnancy. Am Fam Physician. 2008 ; 78 (1). 93-100
181. Sibai B, Dekker G, Kupferminc M.. Pre-eclampsia. Lancet. 2005 ; 365 (9461). 785-799 (Pubitemid 40311367)
182. Coppage KH, Sibai BM.. Treatment of hypertensive complications in pregnancy. Curr Pharm Des. 2005 ; 11 (6). 749-757 (Pubitemid 40347978)
183. Sekine T, Miura K, Takahashi K, Igarashi T.. Children's toxicology from bench to bed-Drug-induced renal injury (1): The toxic effects of ARB/ACEI on fetal kidney development. J Toxicol Sci. 2009 ; 34 (suppl 2). SP245 - SP250
184. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993 ; 270 (7). 854-859
185. Knake S, Hamer HM, Rosenow F.. Status epilepticus: a critical review. Epilepsy Behav. 2009 ; 15 (1). 10-14
186. Euser AG, Cipolla MJ.. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009 ; 40 (4). 1169-1175